4 Million Americans Disabled. 3 NIH Treatment Trials. Zero Patients Enrolled.
1 so far! Help us get to 5 signers!
Millions of Americans have developed a serious illness that can destroy their ability to work, care for their families, or even leave their homes.
A 2026 study estimated that 3.8 million American adults had disabling Long COVID during 2022–2023. Years later, there is still no FDA-approved treatment specifically for the disease.
In September 2025, the National Institutes of Health announced three new treatment trials.
Fourteen months later, not one had begun enrolling patients as of November 4.
Two trials have now received FDA clearance to proceed. NIH says enrollment may begin before the end of 2026, but has not committed to public start dates. Officials also acknowledge having funding for potential additional trials without a defined plan for which treatments will be tested next.
Every month these studies remain unopened delays the search for treatments that could restore people’s health, independence, and livelihoods.
Congress must ensure that federal research moves beyond announcements and delivers measurable progress toward treatments.
I urge Congress to use its oversight and funding authority to require NIH to:
1. Publish a treatment-trial action plan by December 11, with enrollment dates, completion milestones, remaining obstacles, and explanations for delays.
2. Account for available research funding and establish deadlines for selecting and launching additional treatment trials.
3. Ensure severely disabled and housebound patients can participate, including through remote and home-based procedures wherever medically feasible.
4. Report progress quarterly, with congressional hearings and corrective action when commitments are missed.
Rigorous science and patient safety are essential. So are urgency, transparency, and accountability.
Millions have already lost years of their lives. Congress must not allow preventable delays to cost them more.